Virax Biolabs Group Limited - Ordinary Shares (VRAX)
1.6100 0.00 (0.00%)
Virax Biolabs Group Limited is a biotechnology company focused on developing and commercializing innovative diagnostic solutions and therapeutics for viral infections, particularly in the fields of healthcare and disease prevention. The company leverages advanced technologies to create accurate diagnostic kits that aim to identify various viral pathogens, thereby aiding in effective disease management and treatment strategies. Virax is committed to enhancing global health outcomes by providing accessible and reliable testing solutions, which play a critical role in the early detection and monitoring of viral diseases.